A systematic review informing the management of... (2023 study) Skip to main content
Systematic Review Int J Radiat Oncol Biol Phys 2023

A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and ISRS recommendations

Vellayappan B, Kazmi F, Jang RW, et al., Int J Radiat Oncol Biol Phys, 2023

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

The researchers reviewed published studies on treatments for brain radiation necrosis, a type of brain tissue damage that can follow stereotactic radiosurgery, in patients whose symptoms did not respond to corticosteroids.

What They Found

This systematic review of 21 articles, only 2 of them prospective, pooled results for bevacizumab, laser interstitial thermal therapy (LITT), and surgery, and found symptom or imaging improvement or stability in most patients for each. Bevacizumab had a pooled symptom improvement or stability rate of 86% (95% CI 77% to 92%). LITT had a pooled T1 postcontrast improvement or stability rate of 88%, and surgery had a pooled symptom improvement or stability rate of 89%. Only 1 report was relevant for hyperbaric oxygen therapy, and the abstract gives no pooled result for it. Toxicity was inconsistently reported but was generally low for all treatments. The authors did not directly compare the treatments with each other.

What This Means for Canadian Patients

For corticosteroid-refractory radiation necrosis that does not need urgent surgery, the authors strongly recommend bevacizumab in carefully selected patients. The abstract does not make a recommendation about hyperbaric oxygen therapy and reports no results for it. Anyone dealing with radiation necrosis should discuss the options with their treating team.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The authors state that the overall evidence for each treatment is of low quality, most included studies were not prospective, toxicity was inconsistently reported, and the treatments were not directly compared.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Systematic Review
Category Radiation Injury
Source Pubmed
PubMed ID 37482137
Year Published 2023
Journal Int J Radiat Oncol Biol Phys

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology